Comment

Comment by danielmarkbruce

Phase 1 isn't the big problem. It's phase 2 and phase 3 where drugs fail hard and the trials cost the most and take the longest.

Honestly once you go through all the details... drug discovery feels like the one of the overhyped and unlikely to work areas for AI. Other areas of medicine (like diagnosis) are already seeing pretty good results, and anecdotally seems to work well and tends to fit within the realm of text analysis where most of the AI gains have happened.

Discussion

Live from the official Hacker News API

A modern reader for Hacker News · SvelteKit + Skeleton